Hypoxia-induced increase in the production of extracellular matrix proteins in systemic sclerosis.

OBJECTIVE Insufficient angiogenesis with tissue ischemia and accumulation of extracellular matrix are hallmarks of systemic sclerosis (SSc). Based on the severely decreased oxygen levels in the skin of patients with SSc, we aimed to investigate the role of hypoxia in the pathogenesis of SSc. METHODS Subtractive hybridization was used to compare gene expression in dermal fibroblasts under hypoxic and normoxic conditions. Dermal fibroblasts were further characterized by exposure to different concentrations of oxygen and for different time periods as well as by interference with hypoxia-inducible factor 1alpha (HIF-1alpha). The systemic normobaric hypoxia model in mice was used for in vivo analyses. RESULTS Several extracellular matrix proteins and genes involved in extracellular matrix turnover, such as thrombospondin 1, proalpha2(I) collagen, fibronectin 1, insulin-like growth factor binding protein 3, and transforming growth factor beta-induced protein, were induced by hypoxia in SSc and healthy dermal fibroblasts. The induction of these genes was time- and dose-dependent. Experiments with HIF-1alpha-knockout mouse embryonic fibroblasts, deferoxamine/cobalt ions as chemical stabilizers of HIF-1alpha, and HIF-1alpha small interfering RNA consistently showed that extracellular matrix genes are induced in dermal fibroblasts by HIF-1alpha-dependent, as well as HIF-1alpha-independent, mechanisms. Using the systemic normobaric hypoxia mouse model, we demonstrated that dermal hypoxia leads to the induction of the identified extracellular matrix genes in vivo after both short exposure and prolonged exposure to hypoxia. CONCLUSION These data show that hypoxia contributes directly to the progression of fibrosis in patients with SSc by increasing the release of major extracellular matrix proteins. Targeting of hypoxia pathways might therefore be of therapeutic value in patients with SSc.

[1]  C. Cho,et al.  Hypoxia induces expression of connective tissue growth factor in scleroderma skin fibroblasts , 2006, Clinical and experimental immunology.

[2]  W. Kaelin,et al.  The von Hippel-Lindau protein, HIF hydroxylation, and oxygen sensing. , 2005, Biochemical and biophysical research communications.

[3]  U. Müller-Ladner,et al.  Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis. , 2005, Arthritis and rheumatism.

[4]  J. Pilewski,et al.  Insulin-like growth factor binding proteins 3 and 5 are overexpressed in idiopathic pulmonary fibrosis and contribute to extracellular matrix deposition. , 2005, The American journal of pathology.

[5]  Till Acker,et al.  Uncontrolled Expression of Vascular Endothelial Growth Factor and Its Receptors Leads to Insufficient Skin Angiogenesis in Patients With Systemic Sclerosis , 2004, Circulation research.

[6]  D. Livingston,et al.  Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway. , 2004, Cancer cell.

[7]  R. Wenger,et al.  Cellular adaptation to hypoxia: O2‐sensing protein hydroxylases, hypoxia‐inducible transcription factors, and O2‐regulated gene expression , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  D. Wendum,et al.  Hypoxia‐induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis , 2002, Hepatology.

[9]  M. Gassmann,et al.  HIF‐1 is expressed in normoxic tissue and displays an organ‐specific regulation under systemic hypoxia , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  Wei-jian Zhang,et al.  α‐Lipoic acid inhibits TNF‐a‐induced NF‐κB activation and adhesion molecule expression in human aortic endothelial cells , 2001 .

[11]  P. Komminoth,et al.  Deletion at 3p25.3–p23 is frequently encountered in endocrine pancreatic tumours and is associated with metastatic progression , 2001, The Journal of pathology.

[12]  T. Medsger,et al.  Criteria for the classification of early systemic sclerosis. , 2001, The Journal of rheumatology.

[13]  A. D'ercole,et al.  Hepatic mRNAs up‐regulated by starvation: an expression profile determined by suppression subtractive hybridization , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  Eun-Joung Moon,et al.  Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes , 2001, Nature Medicine.

[15]  M. Gassmann,et al.  Epolones induce erythropoietin expression via hypoxia-inducible factor-1α activation , 2000 .

[16]  J. Rosenbloom,et al.  Extracellular matrix and nuclear localization of βig‐h3 in human bladder smooth muscle and fibroblast cells , 2000 .

[17]  M. Gassmann,et al.  General applicability of chicken egg yolk antibodies: the performance of IgY immunoglobulins raised against the hypoxia‐inducible factor 1α , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  R. Hesselstrand,et al.  Mortality and causes of death in a Swedish series of systemic sclerosis patients , 1998, Annals of the rheumatic diseases.

[19]  Jessica Lo,et al.  HIF‐1α is required for solid tumor formation and embryonic vascularization , 1998 .

[20]  J. Norman,et al.  Hypoxia stimulates proximal tubular cell matrix production via a TGF-beta1-independent mechanism. , 1997, Kidney international.

[21]  Takeshi Kawamoto,et al.  Characterization of a cartilage-derived 66-kDa protein (RGD-CAP/beta ig-h3) that binds to collagen. , 1997, Biochimica et biophysica acta.

[22]  T. Zderic,et al.  βig-h3, a Transforming Growth Factor–β–Inducible Gene, Is Overexpressed in Atherosclerotic and Restenotic Human Vascular Lesions , 1996 .

[23]  R. LeBaron,et al.  Beta IG-H3, a novel secretory protein inducible by transforming growth factor-beta, is present in normal skin and promotes the adhesion and spreading of dermal fibroblasts in vitro. , 1995, The Journal of investigative dermatology.

[24]  M. Sporn,et al.  Transforming growth factor-beta: selective increase in glycosaminoglycan synthesis by cultures of fibroblasts from patients with progressive systemic sclerosis. , 1987, The Journal of investigative dermatology.

[25]  U. Müller-Ladner,et al.  Monocyte chemoattractant protein 1 released from glycosaminoglycans mediates its profibrotic effects in systemic sclerosis via the release of interleukin-4 from T cells. , 2006, Arthritis and rheumatism.

[26]  Oliver Distler,et al.  Physiologic responses to hypoxia and implications for hypoxia-inducible factors in the pathogenesis of rheumatoid arthritis. , 2004, Arthritis and rheumatism.

[27]  M. Cerinic,et al.  Raynaud's phenomenon and vascular disease in systemic sclerosis. , 1999, Advances in experimental medicine and biology.

[28]  R. Bashey,et al.  Regulation of connective tissue synthesis in systemic sclerosis. , 1995, International reviews of immunology.